Evidence map›Paper›PMID 39671459›Full record

ArticlePLoS computational biology2024

ClustAll: An R package for patient stratification in complex diseases.

Asier Ortega-Legarreta, Sara Palomino-Echeverria, Estefania Huergo, Vincenzo Lagani, Narsis A Kiani, Pierre-Emmanuel Rautou, Nuria Planell Picola, Jesper Tegner, David Gomez-Cabrero

Abstract read
In one paragraph

Article in PLoS computational biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Asier Ortega-LegarretaUnit of Translational Bioinformatics, Navarrabiomed-Fundación Miguel Servet, Universidad Publica de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Sara Palomino-EcheverriaUnit of Translational Bioinformatics, Navarrabiomed-Fundación Miguel Servet, Universidad Publica de Navarra (UPNA), IdiSNA, Pamplona, Spain.ORCID 0000-0002-0451-3749
Estefania HuergoUnit of Translational Bioinformatics, Navarrabiomed-Fundación Miguel Servet, Universidad Publica de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Vincenzo LaganiBiological and Environmental Science and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
Narsis A KianiAlgorithmic Dynamics lab, Karolinska Institutet, Solna, Sweden.
Pierre-Emmanuel RautouUniversité Paris-Cité, Inserm, Centre de recherche sur l'inflammation, UMR, Paris, France.
Nuria Planell PicolaComputational Biology Program, Universidad de Navarra, CIMA, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Navarra, Spain.
Jesper TegnerBiological and Environmental Science and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia.
David Gomez-CabreroUnit of Translational Bioinformatics, Navarrabiomed-Fundación Miguel Servet, Universidad Publica de Navarra (UPNA), IdiSNA, Pamplona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the era of precision medicine, it is necessary to understand heterogeneity among patients with complex diseases to improve personalized prevention and management strategies. Here, we introduce ClustAll, a Bioconductor package designed for unsupervised patient stratification using clinical data. ClustAll is based on the previously validated methodology ClustAll, a clustering framework that effectively handles intricacies in clinical data, including mixed data types, missing values, and collinearity. Additionally, ClustAll stands out in its ability to identify multiple patient stratifications within the same population while ensuring their robustness. The updated implementation of ClustAll features S4 classes, parallel computing for enhanced computational efficiency, and user-friendly tools for exploring and comparing stratifications against clinical phenotypes. The performance of ClustAll has been validated using two public clinical datasets, confirming its effectiveness in patient stratification and highlighting its potential impact on clinical management. In summary, ClustAll is a powerful tool for patient stratification in personalized medicine.

Indexed as

Computational BiologyPrecision MedicineSoftwareAlgorithmsCluster AnalysisHumansPhenotype

Identifiers

PMID39671459
PMCPMC11676920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.